AARTIDRUGS — Aarti Drugs Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹46.39bn
- IN₹51.82bn
- IN₹25.29bn
- 89
- 30
- 62
- 68
Annual cashflow statement for Aarti Drugs, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | C2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 1,853 | 3,690 | 2,700 | 2,242 | 2,355 |
| Depreciation | |||||
| Non-Cash Items | 381 | 187 | 204 | 348 | 316 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -214 | -2,827 | -2,707 | -1,751 | 404 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 2,507 | 1,550 | 696 | 1,342 | 3,589 |
| Capital Expenditures | -480 | -882 | -1,520 | -1,648 | -2,263 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 148 | 165 | 31.1 | 8.46 | 26.8 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -332 | -718 | -1,489 | -1,640 | -2,237 |
| Financing Cash Flow Items | -352 | -230 | -344 | -362 | -446 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -2,154 | -811 | 920 | 165 | -1,360 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 21.3 | 20.4 | 128 | -132 | -7.6 |